Abstract Topics

 
• Phytocannabinoid study – strains, chemovars, entourage and molecules

• Pharamacokinetics and pharmacodynamics of cannabinoids

• Prediction of response to cannabinoid treatment

• Clinical trials targeting Pain, GI Disorders, Palliative Care, Psychiatry and Neurological disorders 

• New designs for cannabis clinical trials (including pragmatic trials and n=1) 

• Clinical Registries

• Observational / Epidemiological studies: findings, interpretations, plans 

• Phase 2/3/4 study findings and designs (including special populations) 

• Meta- and composite- analyses: findings and methodology 

• Regulatory, licensing, and development programme issues and plans 

• Cannabinoid trial best conduct including GCP and site training 

• Assessing safety of cannabinoid medications 

• Innovative route of administration (ROA) and titration technologies 

• Big data and cannabis

• Cannabinoids and Opioids